Loading
Latest filing published 11 Mar 2026 for Hansa Biopharma AB, €4,689. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Only one filing by Sandra Boström Frithiof is known so far (11 March 2026): an open-market purchase, €4,689, in Hansa Biopharma AB. That is too little to draw conclusions. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration